R±CEOP90 Versus R±CEOP75 in Newly Diagnosed Young Patients With Medium/High-risk DLBCL

Clinical trial NCT03151044 · UNKNOWN

Trial details

NCT number: NCT03151044
Sponsor: FENG Ji-feng
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Diffuse Large B-cell Lymphoma

Start date: 2016-07-01
Primary completion: 2017-07-01
Enrollment: 408

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.